首页> 美国卫生研究院文献>Comparative Medicine >Severe Periocular Edema after Intraarterial Carboplatin Chemotherapy for Retinoblastoma in a Rabbit (Oryctolagus cuniculus) Model
【2h】

Severe Periocular Edema after Intraarterial Carboplatin Chemotherapy for Retinoblastoma in a Rabbit (Oryctolagus cuniculus) Model

机译:兔(Oryctolagus cuniculus)模型中的视网膜母细胞瘤后的严重围眼水肿化疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Endovascular microcatheter-based intraarterial (ophthalmic artery) chemotherapy is becoming widely used for the clinical treatment of intraocular retinoblastoma due to its apparent increased efficacy compared with traditional intravenous chemotherapy; however local ocular complications are not uncommon. Carboplatin is a chemotherapeutic agent used in both intravenous and intraarterial chemotherapy. We used rabbits to assess pharmacokinetics and ocular and systemic toxicity after intraarterial carboplatin infusion. Subsequent to unilateral intraarterial administration of carboplatin, severe unilateral or bilateral periocular edema occurred in 6 adult male New Zealand white rabbits. Time to onset varied from less than 4 h after administration (n = 3, 50 mg) to approximately 24 h afterward (n = 3, 25 mg). After becoming symptomatic, 5 of the 6 animals were promptly euthanized, and the remaining animal (25 mg treatment) was medically managed for 4 d before being euthanized due to intractable edema-related lagophthalmos. Globes and orbits from all 6 euthanized rabbits were harvested en bloc; whole-mount sections were prepared for histologic evaluation, which revealed drug-induced vasogenic edema in confined spaces as the main underlying pathogenesis. Transient and self-limiting periocular edema is a common side effect of intraarterial chemotherapy but is thought to occur predominantly with melphalan monotherapy or combination therapy using melphalan, carboplatin, and topotecan. The severity of this adverse consequence in rabbits was unexpected, and its use in the study was subsequently discontinued. Although the definitive cause for this vasotoxicity and striking clinical presentation is unknown, we suspect species-specific anatomic features and sensitivity might have contributed to amplified complications after intraarterial carboplatin chemotherapy of the eye. Due to the adverse effects of intraarterial carboplatin chemotherapy that we observed in 2 experimental cohorts of rabbits, we recommend caution regarding its use in this species.
机译:基于血管血管微直接导管的动脉内(眼科动脉)化疗越来越广泛地用于人工视网膜母细胞瘤的临床治疗,与传统的静脉化疗相比其显而易见的疗效;然而,局部眼部并发症并不罕见。卡铂是一种用于静脉内和眼内化疗的化学治疗剂。我们使用Rabbits在动脉内卡铂输注后评估药代动力学和眼科和系统性毒性。随后在单侧动脉内施用卡铂,严重单侧或双侧围眼水肿发生在6名成年男性新西兰白兔。在施用(n = 3,50mg)后,在施用(n = 3,50mg)至大约24小时(n = 3,25mg)之后,令人变化的时间在少于4小时。在成为症状后,6只动物中有5只被安动死,并且剩余的动物(25mg治疗)在被安乐死之前,在被安乐死之前医学管理,因为具有顽固的水肿相关的横噬菌体。所有6个安乐死的兔子的地球和轨道被收获了en bloc;为组织学评估制备整个安装部分,其揭示了被狭窄的空间中的药物诱导的血管内水肿,作为主要的潜在潜在的发病机制。短暂和自我限制的围眼水肿是眼内化疗的常见副作用,但被认为主要用Melphalan单药治疗或使用Melphalan,Carboplatin和Topotecan的联合治疗发生。兔子这种不良后果的严重程度意外,随后停止了该研究的使用。虽然这种血管毒性和引人注目的临床表现的最终原因是未知的,但我们怀疑物种特异性的解剖学特征和敏感性可能导致眼睛的眼动脉内卡铂化疗后的扩增并发症。由于在2种实验队伍中观察到的兔子的内腔卡铂化疗的不良反应,我们建议在本物种中使用谨慎。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号